Basics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Similar documents
Basics of Benzodiazepine Use Disorder. DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

Medications For Alcohol Use Disorder

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

MEDICATION ALGORITHM FOR ANXIETY DISORDERS

Treatment of Anxiety (without benzos)

Using Benzodiazepines in Primary Care

Strategies in Managing Opioid and Benzodiazepine Co-Prescribing

Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation. Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project

Marijuana. DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM

Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM

WHAT SHOULD WE DO ABOUT BENZODIAZEPINES? Miriam Komaromy, MD Associate Director, Project ECHO August 2014

Managing presenting problems with benzodiazepines. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

ANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN

Difficult Conversations

Anxiety Disorders.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Sedative / Hypnotics

Identification and Management of Benzodiazepine and Z-drug abuse

Benzodiazepines. Benzodiazepines

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

BENZODIAZEPINES: WHAT YOU DON T KNOW CAN HURT YOU

Treating Anxiety Disorders. Adil Virani, BSc (Pharm), Pharm D, FCSHP

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

Vistaril ( hydroxyzine ) is a non-addictive antihistamine medication. This drug is used to relieve the itching caused by allergies and to control the

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Can klonopin help withdrawal opiates

Sedatives and Hypnotics. Ahmad Al-Tarifi. Zahra Khalil. Pharmacology. 1 P a g e

Multiple Choice Questions

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.

Mixing and Matching: Layering Medications as Family Physicians

ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS

SCENARIOS IN SUBSTANCE MISUSE. By Dr Gideon Felton Consultant Psychiatrist and Clinical Lead

Acute General Medical and Surgical Admission:

Disclosures. Objectives. Symptoms of fear. The Fifteen Minute Hour: Psychotherapy & Medications for Anxiety Management in Primary Care 4/5/18

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

Session 2: Mental Health A: Alcohol Dependency: The Pharmacist s Role in Detox and Treatment 1:45pm - 2:45pm

OLDER ADULTS & DEPRESCRIBING: TREATMENT

11/1/2010. Psychology 472 Pharmacology of Psychoactive Drugs. Listen to the audio lecture while viewing these slides

Benzodiazepines Information for GPs

6/27/2017. Disclosures. Overview. Case Overview

DRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS

Managing Pain in the Patient with Opioid Use Disorder: Inpatient Management. Melissa Weimer, DO, MCR Oregon Health & Science University

Current Clinical Patterns in the Management of Alcohol Withdrawal Syndrome (AWS)

Antidepressant Medication Therapy in Primary Care July 25, 2013

Treatment of Alcohol and Opiate Withdrawal

ANTICONVULSANTS IN ALCOHOL WITHDRAWAL TREATMENT: A BETTER WAY?

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

Opioid Use Disorder Treatment: Buprenorphine Treatment Basics

Dr Chris Ford Clinical Director IDHDP (International Doctors for Healthy Drug Policies) Thursday 16 th May 2013

Anxiolytic & Hypnotic Drugs. Asst Prof Dr Inam S Arif

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

Buprenorphine 2.0: I have my waiver, now what? Dr. Ritu Bhatnagar, M.D., M.P.H. Dr. John Ewing, M.D., FASAM. Disclosures

An algorithm for medication in the treatment of Complex PTSD

Medications Guide: Public Speaking And Social Anxiety

Benzodiazepines. CRIT program May Alex Walley, MD, MSc Assistant Professor of Medicine Boston University School of Medicine

Pharmacological Treatment of Anxiety & Depressive Disorders

Treating Pain and Depression

BOOTS ON THE GROUND CRUCIAL CONVERSATIONS RELATED TO MEDICATION TAPERING

GUIDELINES FOR THE USE OF PSYCHOACTIVE MEDICATIONS IN INDIVIDUALS WITH CO-OCCURRING SUBSTANCE USE DISORDERS

Depression & Anxiety in Adolescents

Tapering off ativan.5

7/7/2016 Journal of the American Medical Association,

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

Alcohol 2: Case Examples

Pharmacotherapy of Anxiety Disorders (GAD, Panic, & SAD) Declaration of Interests

USUAL DOSE OF XANAX. Usual Dose Of Xanax

Disclosures. Overview of Workshop. Objectives. Medical Care of Vulnerable and Underserved Populations: Advanced Cases in Anxiety and Depression

Anxiety Disorders.

Start Low, Go Slow but Treat to Target

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Tapering Opioids Best Practices*

THEXANAX THREAT 1 THE XANAX THREAT. iaddiction.com

VA/DoD Clinical Practice Guideline for Management of Post Traumatic Stress. Core Module

Withdrawal.

Managing presenting alcohol users an Introduction to SPECTRUM (CRI) By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

Psychiatric Medication Guide

Co-Occurring Mental Health and Substance Use Disorders. DATE: 4/17/18 PRESENTED BY: John Mahan, MD

Tranquilizers & Sedative-Hypnotics

Opioids Research to Practice

Client Session:3004, John, Aug 03, 2017, jh. CARS Diagnostic Report Prepared for: jh TABLE OF CONTENTS

Medications for Borderline Personality Disorder

Substance Misuse and Abuse

Treatment Options for Bipolar Disorder Contents

Treatment of Substance Use Disorders in the Real World. Jessica M. Peirce, Ph.D. Johns Hopkins University School of Medicine

AN OVERVIEW OF ANXIETY

Safe Alprazolam Prescribing and Benzodiazepine Monitoring Program

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE

Management of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013

Anxiety: Cure For Anxiety, Fear, Panic & Techniques For Stress By Zac Dixon READ ONLINE

Mental Health Nursing: Anxiety Disorders. By Mary B. Knutson, RN, MS, FCP

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY

Transcription:

Basics of Benzodiazepine Use Disorder DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members of the planning committee (Jessica Gregg, Todd Korthuis, Melissa Weimer, John Mahan, Laura Heesacker, O Nesha Cochran, and Chris Colasurdo) have nothing to disclose. Dr. Korthuis serves as principal investigator for NIH-funded research that accepts donated extended-release naltrexone (Alkermes) and buprenorphine/naloxone (Indivior). 2 2

Objectives Understand the mechanism of action and pharmacokinetic properties of benzodiazepines Understand that differentiating between benzodiazepine physiologic dependence and benzodiazepine use disorder may be challenging Describe how to safely taper benzodiazepine therapy 3 3

Benzos are positive allosteric modulators Increase the GABA A receptor s affinity for GABA

Symptom Acute Withdrawal Symptoms: occur after 10-21 days of continuous use Higher dose, longer use = more symptoms Lower dose, shorter term use = less symptoms Insomnia 71% Anxiety 56% Mood swings 49% Muscle twitching 49% Tremor 38% Headache 38% Nausea, vomiting, anorexia 36% Frequency Hypersensitivity to smells, sounds, lights, noise, touch Up to 38% Seizure* 4% Jahnsen, 2015 https://www-ncbi-nlm-nih-gov.liboff.ohsu.edu/pmc/articles/pmc4318457/pdf/dtsch_arztebl_int-112-0001.pdf *Hx of prior seizure = risk of seizure again*

Features of a Benzo Use Disorder vs Benzo physiologic dependence Tolerance Withdrawal When severe, these 2 issues can cause problems with their life, ability to cope Benzo dependence alone Benzo use disorder Tolerance Withdrawal Loss of control of use Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Case Example 1 Real case Joe is a 72 yo man with HTN and hyperlipidemia. He developed severe anxiety after retirement approximately 10 years ago and was prescribed lorazepam 1mg BID. He found it helped him at first, but now he feels like it is a crutch and he doesn t like the effect his wife says it has on him. He would like to stop the medication but every time he stops, he becomes sweaty, fearful, anorexic and can not sleep. He would like to stop the medication before he goes on a cruise in 10 days. He has been erratically taking his meds over the last 2 weeks in an attempt to stop them, but has not been able to sleep and feels horrible.

Features of a Benzo Use Disorder vs Benzo physiologic dependence Tolerance Withdrawal Benzo dependence alone Benzo use disorder Tolerance Withdrawal Loss of control of use Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Taper plan outpatient slow taper Enjoy your vacation on a stable dose of lorazepam 1mg BID Start benzodiazepine taper when you return Consider transition to clonazepam or diazepam http://www.globalrph.com/benzodiazepine_calc.htm Taper by 10-25% per week depending on how well patient tolerates each step of the taper and dose availability Start mirtazapine and melatonin for sleep Create sleep routine and cut out naps Refer for cognitive behavioral therapy (CBT) Find hobbies or volunteer work

Taper Example: Clonazepam 0.5mg BID x 2 weeks Check in Clonazepam 0.5mg in AM and 0.25mg in PM x 2 weeks Check in Clonazepam 0.25mg BID x 2 weeks Check in Clonazepam 0.25mg in AM and 0.125mg In PM x 2 weeks Check in Clonazepam 0.125mg BID x 2 weeks Check in Clonazepam 0.125mg QAM x 2 weeks Check in Clonazepam 0.125mg every other day x 2 weeks Check in STOP

Case Example 2 Real case Joanne is a 52 year old female with hx of PTSD and major recurrent depression who seeks care in your primary care clinic for help getting off of benzos. She has been prescribed benzos (diazepam) since age 20 and has tried several times to stop them. She has developed a social phobia about psychiatrists. She can not go longer than 4 hours between doses or she has severe panic, though she does not take them more than prescribed to her. She has completely isolated herself from family and friends, can not work and feels completely disabled. Her friend recently drove to FL to pick her up because she was so distraught over her use and inability to stop benzodiazepines and her current prescriber is threatening to cut her off. She desperately wants to stop and her friend plans to help her and support her.

Features of a Benzodiazepine Use Disorder vs Benzodiazepine dependence Benzo physiologic dependence Tolerance Withdrawal Benzo use disorder Tolerance Withdrawal Loss of control of use?? Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Taper plan: outpatient prolonged taper Stabilize patient over 1-2 weeks on a dose of long acting benzodiazepines (clonazepam) mostly equivalent to her current prescription for diazepam Care coordinate with her friend to help manage medication and inform you if there are any issues Keep a log and lock on the medications Consider inpatient treatment if this doesn t go well Start very slow taper by reducing clonazepam by 0.25-0.125mg every 2 weeks Add PROPRANOLOL due to patient avoidance of all other meds Taper takes 1 year and is successful Patient engages in NA meetings for support

Case 3: REAL case Jimmy is a 22 year old man with hx of tobacco use who has been ordering a research benzodiazepine (etizolam) from CA for the last year. Total dose of 20mg per day. He also drinks a 6 pack of beer per day. He has received a DWI due to driving while intoxicated. He has had 2 seizures in the past due to attempting to taper his use on his own. He feels restless, anxious, sweaty, and continual vomiting. He would like to get back to work for the parks service as soon as possible. His parents have threatened to kick him out of the house if he does not stop his use.

Features of a Benzo Use Disorder vs Benzo physiologic dependence Tolerance Withdrawal Benzo dependence alone Benzo use disorder Tolerance Withdrawal Loss of control of use Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Taper plan INPATIENT TAPER Inpatient admission for detoxification Start Depakote 250mg TID, continue 3 weeks Schedule Librium 50-100mg QID x 1 day and then reduce by 25-50mg per day depending on time in detox Fastest inpatient taper = 5-7 days Longest inpatient taper = 10-14 days Continue PRN Librium based on CIWA scale as well Work with family on safe discharge plan Advise against working or driving for the next week, minimum Start hydroxyzine, buspirone, trazodone to help with symptom relief Refer for treatment

Alternatives to Benzos for anxiety Prazosin or Clonidine Propranolol Quetiapine Mirtazepine SSRIs Hydroxyzine Buspirone Gabapentin* List is not in order of preference and not an exhaustive list Always choose a medication best suited for the specific problem you are attempting to address Consider TRAUMA and PTSD *Beware of possible diversion risk

Final Pearls Patients with significant liver disease Use benzos that undergo glucuronide conjugation Lorazepam, oxazepam CAUTION: Chlordiazepoxide, clonazepam, diazepam Don t attempt to taper opioids and benzos at the same time unless there is a significant safety issue Engage patients in other forms of coping CBT DBT Understand that relapse may occur

Questions? http://www.globalrph.com/benzodiazepine_calc.htm Soyka, Treatment of Benzodiazepine Dependence. NEJM 376; 12. March 23, 2017 http://www.oregonpainguidance.org/app/content/uploads/2016/ 05/Opioid-and-Benzodiazepine-Tapering-flow-sheets.pdf

Withdrawal Management Soyka, 2017 4-8 weeks to taper, maybe longer, but not too long 10-50% in first week Hospitalize if > 100mg diazepam equivalents Don t withdraw opioids at the same time Adjuncts: gabapentin, carbamazepine or depakote, SSRIs, TCAs, antihistamines (i.e. hydroxyzine), melatonin Limited evidence for AEDs, but still consider

Benzodiazepine Metabolism Glucuronide Conjugation o Shorter half-life o Inactive metabolites o Safer in liver disease and elderly Lorazepam Oxazepam Temazepam (remember LOT) Oxidation o Longer half-life o More metabolites o Use caution in liver disease Chlordiazepoxide Diazepam Clonazepam